143 related articles for article (PubMed ID: 35478268)
21. Ocular features in Alport syndrome: pathogenesis and clinical significance.
Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D
Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157
[TBL] [Abstract][Full Text] [Related]
22. Compound Mutations of the COL4A3 including a Novel Allele Identified in a Patient with Alport Syndrome.
Wang Z; Jiang B; Jin S; Hu Z; Liu G
Biomed Res Int; 2020; 2020():1626378. PubMed ID: 33524082
[TBL] [Abstract][Full Text] [Related]
23. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
Savige J
Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
[TBL] [Abstract][Full Text] [Related]
24. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
Maziers N; Dahan K; Pirson Y
Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
[TBL] [Abstract][Full Text] [Related]
25. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.
Furlano M; Martínez V; Pybus M; Arce Y; Crespí J; Venegas MDP; Bullich G; Domingo A; Ayasreh N; Benito S; Lorente L; Ruíz P; Gonzalez VL; Arlandis R; Cabello E; Torres F; Guirado L; Ars E; Torra R
Am J Kidney Dis; 2021 Oct; 78(4):560-570.e1. PubMed ID: 33838161
[TBL] [Abstract][Full Text] [Related]
26. Thrombosis risk of Alport syndrome patients: evaluation of cardiological, clinical, biochemical, genetic and possible causes of inherited thrombophilia and identification of a novel COL4A3 variant.
Eroz R; Damar İH; Kılıçaslan O
Blood Coagul Fibrinolysis; 2020 Jun; 31(4):264-269. PubMed ID: 32332277
[TBL] [Abstract][Full Text] [Related]
27. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy.
Hou P; Chen Y; Ding J; Li G; Zhang H
Am J Nephrol; 2007; 27(5):538-44. PubMed ID: 17726307
[TBL] [Abstract][Full Text] [Related]
29. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
[TBL] [Abstract][Full Text] [Related]
30. Novel COL4A3 mutations in African American siblings with autosomal recessive Alport syndrome.
Cook C; Friedrich CA; Baliga R
Am J Kidney Dis; 2008 May; 51(5):e25-8. PubMed ID: 18436078
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
Savige J; Harraka P
Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
[TBL] [Abstract][Full Text] [Related]
32. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
[TBL] [Abstract][Full Text] [Related]
33. Macroscopic hematuria with normal renal biopsy-following the chain to the diagnosis: Questions.
Truong J; Deschênes G; Callard P; Antignac C; Niel O
Pediatr Nephrol; 2017 Feb; 32(2):277-278. PubMed ID: 26628277
[TBL] [Abstract][Full Text] [Related]
34. Efficient Targeted Next Generation Sequencing-Based Workflow for Differential Diagnosis of Alport-Related Disorders.
Kovács G; Kalmár T; Endreffy E; Ondrik Z; Iványi B; Rikker C; Haszon I; Túri S; Sinkó M; Bereczki C; Maróti Z
PLoS One; 2016; 11(3):e0149241. PubMed ID: 26934356
[TBL] [Abstract][Full Text] [Related]
35. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
36. Could This Be Alport Syndrome?
Lennon R; Fornoni A
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1743-1745. PubMed ID: 33849931
[No Abstract] [Full Text] [Related]
37. A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.
Uzak AS; Tokgoz B; Dundar M; Tekin M
Genet Test Mol Biomarkers; 2013 Mar; 17(3):260-4. PubMed ID: 23297803
[TBL] [Abstract][Full Text] [Related]
38. [Collagen IV (alpha3-alpha4) nephropathy].
Torra R; Tazón B; Ars E; Ballarín J
Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
[TBL] [Abstract][Full Text] [Related]
39. Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.
Rana K; Tonna S; Wang YY; Sin L; Lin T; Shaw E; Mookerjee I; Savige J
Pediatr Nephrol; 2007 May; 22(5):652-7. PubMed ID: 17216251
[TBL] [Abstract][Full Text] [Related]
40. COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.
Storey H; Savige J; Sivakumar V; Abbs S; Flinter FA
J Am Soc Nephrol; 2013 Dec; 24(12):1945-54. PubMed ID: 24052634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
